发明名称 |
Remedy for the treatment of cardio-vascular diseases or disorders |
摘要 |
Disclosed is the use of inhibitors of β-catenin expression or activity or modulators downregulating β-catenin expression or activity for the treatment of cardiovascular diseases or disorders and their use in the treatment of cardiovascular diseases and disorders, such as heart failure syndrome. The use of those agents resulted in particular in cardiomyocyte differentiation of endogenous cardiac stem cells. |
申请公布号 |
US8969080(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US200912573281 |
申请日期 |
2009.10.05 |
申请人 |
Max-Delbrueck-Centrum fuer Molekulare Medizin |
发明人 |
Bergmann Martin;Huelsken Joerg;Birchmeier Walter;Taketo Makoto Mark |
分类号 |
A61K48/00;A61K31/203;A01K67/027;A61K31/405;A61K31/415;A61K31/711;A61K38/17;C07K14/47;C12N15/85 |
主分类号 |
A61K48/00 |
代理机构 |
Agris & von Natzmer, LLP |
代理人 |
Natzmer Joyce von;Agris & von Natzmer, LLP |
主权项 |
1. A method for differentiating resident cardiac precursor cells comprising:
administering to a subject in need thereof comprising said resident cardiac precursor cells, an inhibitor of β-catenin expression or activity or a modulator downregulating β-catenin expression or activity in an β-catenin expression or activity downregulating effective amount, wherein the administration is targeted towards cardiac cells or tissues, and wherein said administration results in enhanced differentiation of said resident cardiac precursor cells and subsequent regeneration of cardiac tissue. |
地址 |
Berlin DE |